A pilot study of addition of amifostine to melphalan, carboplatin, etoposide, and cyclophosphamide with autologous hematopoietic stem cell transplantation in pediatric solid tumors-A pediatric blood and marrow transplant consortium study. [electronic resource]
Producer: 20080820Description: 204-9 p. digitalISSN:- 1077-4114
- Adolescent
- Adult
- Amifostine -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Bone Marrow Transplantation
- Bone Neoplasms -- diagnosis
- Carboplatin -- administration & dosage
- Central Nervous System Neoplasms -- diagnosis
- Child
- Child, Preschool
- Combined Modality Therapy
- Cyclophosphamide -- administration & dosage
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Drug-Related Side Effects and Adverse Reactions
- Etoposide -- administration & dosage
- Feasibility Studies
- Hematopoietic Stem Cell Transplantation
- Hodgkin Disease -- diagnosis
- Humans
- Hypocalcemia -- chemically induced
- Kidney Neoplasms -- diagnosis
- Melphalan -- administration & dosage
- Neoplasms -- diagnosis
- Neuroblastoma -- diagnosis
- Pilot Projects
- Recurrence
- Risk Factors
- Sarcoma -- diagnosis
- Transplantation, Autologous
- Transplantation, Homologous
- Treatment Outcome
- Wilms Tumor -- diagnosis
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.